Newegg Commerce, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Newegg Commerce, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $21.37M | Mar 18, 2013 |
| FY2012 | Dec 31, 2011 | $21.64M | Mar 18, 2013 |
| FY2011 | Dec 31, 2010 | $19.60M | Mar 19, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $8.12M | Mar 18, 2013 |
| FY2012 | Dec 31, 2011 | $7.94M | Mar 18, 2013 |
| FY2011 | Dec 31, 2010 | $7.62M | Mar 19, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $3.21M | Mar 18, 2013 |
| FY2012 | Dec 31, 2011 | $3.10M | Mar 18, 2013 |
| FY2011 | Dec 31, 2010 | $4.54M | Mar 19, 2012 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $4.39M | Mar 18, 2013 |
| FY2012 | Dec 31, 2011 | $3.61M | Mar 18, 2013 |
| FY2011 | Dec 31, 2010 | $5.13M | Mar 19, 2012 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $230.9K | Mar 18, 2013 |
| FY2012 | Dec 31, 2011 | $268.0K | Mar 18, 2013 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $1.70M | Mar 18, 2013 |
| FY2012 | Dec 31, 2011 | ($3.16M) | Mar 18, 2013 |
| FY2011 | Dec 31, 2010 | ($4.98M) | Mar 19, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $38.28M | Mar 18, 2013 |
| FY2012 | Dec 31, 2011 | $34.98M | Mar 18, 2013 |
| FY2011 | Dec 31, 2010 | $36.88M | Mar 19, 2012 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $4.21M | Mar 18, 2013 |
| FY2012 | Dec 31, 2011 | $4.74M | Mar 18, 2013 |
| FY2011 | Dec 31, 2010 | $11.09M | Mar 19, 2012 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $32.63M | Mar 18, 2013 |
| FY2012 | Dec 31, 2011 | $28.82M | Mar 18, 2013 |
| FY2011 | Dec 31, 2010 | $24.46M | Mar 19, 2012 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $16.15M | Mar 18, 2013 |
| FY2012 | Dec 31, 2011 | $12.94M | Mar 18, 2013 |
| FY2011 | Dec 31, 2010 | $9.84M | Mar 19, 2012 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $3.51M | Mar 18, 2013 |
| FY2012 | Dec 31, 2011 | $3.69M | Mar 18, 2013 |
| FY2012 | Sep 30, 2011 | $2.60M | Mar 18, 2013 |
| FY2012 | Dec 31, 2010 | $5.92M | Mar 18, 2013 |
| FY2011 | Dec 31, 2009 | $1.15M | Mar 19, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | 0 | Mar 18, 2013 |
| FY2012 | Dec 31, 2011 | 0 | Mar 18, 2013 |
| FY2011 | Dec 31, 2010 | 1 | Mar 19, 2012 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | 0 | Mar 18, 2013 |
| FY2012 | Dec 31, 2011 | 0 | Mar 18, 2013 |
| FY2011 | Dec 31, 2010 | 1 | Mar 19, 2012 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | 4.62M | Mar 18, 2013 |
| FY2012 | Dec 31, 2011 | 4.56M | Mar 18, 2013 |
| FY2011 | Dec 31, 2010 | 4.50M | Mar 19, 2012 |